PTK6 downregulation also inhibited 3D growth of ER+ breast cancer cells made resistant to tamoxifen treatment by continuous drug exposure (MCF-7L-TamR and T47D-TamR cells)32,33 (Fig. 2b). The gene discussed is PTK6; the disease is breast carcinoma.